Health Canada approves Zolgensma®, the one-time gene therapy for pediatric patients with spinal muscular atrophy ...
Canada NewsWire - 16 Dec 2020Health Canada approves Zolgensma®, the one-time gene therapy for pediatric patients with spinal muscular atrophy ... ...